Torsten Dahlén

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: LANCET DIGITAL HEALTH. 2024;6(2):e105-e113

Using routine health-care data to search for unknown transfusion-transmitted disease: a nationwide, agnostic retrospective cohort study.

Dahlén T; Zhao J; Busch MP; Edgren G
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2023;330(10):941-950

Intracerebral Hemorrhage Among Blood Donors and Their Transfusion Recipients.

Zhao J; Rostgaard K; Lauwers E; Dahlén T; Ostrowski SR; Erikstrup C; Pedersen OB; de Strooper B; Lemmens R; Hjalgrim H; Edgren G
Article: JOURNAL OF INTERNAL MEDICINE. 2023;293(3):398-402

A population-based, retrospective cohort study of the association between ABO blood group and risk of COVID-19.

Dahlén T; Li H; Nyberg F; Edgren G
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2022;11(11):e024091

Neutrophil-to-Lymphocyte Ratios in Patients Undergoing Aortic Valve Replacement: The PARTNER Trials and Registries.

Shahim B; Redfors B; Lindman BR; Chen S; Dahlen T; Nazif T; Kapadia S; Gertz ZM; Crowley AC; Li D; Thourani VH; Kodali SK; Zajarias A; Babaliaros VC; Guyton RA; Elmariah S; Herrmann HC; Cohen DJ; Mack MJ; Smith CR; Leon MB; George I
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2022;97(4):421-430

Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study.

Dahlén T; Edgren G; Ljungman P; Flygt H; Richter J; Olsson-Strömberg U; Wadenvik H; Dreimane A; Myhr-Eriksson K; Zhao J; Själander A; Höglund M; Stenke L
Article: JOURNAL OF INTERNAL MEDICINE. 2022;291(1):95-100

The frequency of misattributed paternity in Sweden is low and decreasing: A nationwide cohort study.

Dahlén T; Zhao J; Magnusson PKE; Pawitan Y; Lavröd J; Edgren G
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;193(5):915-921

Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry.

Flygt H; Sandin F; Dahlén T; Dremaine A; Lübking A; Markevärn B; Myhr-Eriksson K; Olsson K; Olsson-Strömberg U; Själander A; Söderlund S; Wennström L; Wadenvik H; Stenke L; Höglund M; Richter J
Article: VOX SANGUINIS. 2021;116(5):581-590

Costs associated with transfusion therapy in patients with myelodysplastic syndromes in Sweden: a nationwide retrospective cohort study.

Zhao J; Dahlén T; Edgren G
Article: ELIFE. 2021;10:e65658

An agnostic study of associations between ABO and RhD blood group and phenome-wide disease risk.

Dahlén T; Clements M; Zhao J; Olsson ML; Edgren G
Article: TRANSFUSION. 2020;60(11):2591-2596

Risk of hematological malignancy in blood donors: A nationwide cohort study.

Zhao J; Dahlén T; Brynolf A; Edgren G
Article: PLOS COMPUTATIONAL BIOLOGY. 2020;16(6):e1007927

Measurable health effects associated with the daylight saving time shift.

Zhang H; Dahlén T; Khan A; Edgren G; Rzhetsky A
Article: NATURE COMMUNICATIONS. 2019;10(1):5508

Estimating heritability and genetic correlations from large health datasets in the absence of genetic data.

Jia G; Li Y; Zhang H; Chattopadhyay I; Boeck Jensen A; Blair DR; Davis L; Robinson PN; Dahlén T; Brunak S; Benson M; Edgren G; Cox NJ; Gao X; Rzhetsky A
Article: APPLIED HEALTH ECONOMICS AND HEALTH POLICY. 2019;17(4):555-567

Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia.

Hirt C; Iannazzo S; Chiroli S; McGarry LJ; le Coutre P; Stenke L; Dahlén T; Lipton JH
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2017;98(1):57-66

Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.

Söderlund S; Dahlén T; Sandin F; Olsson-Strömberg U; Creignou M; Dreimane A; Lübking A; Markevärn B; Själander A; Wadenvik H; Stenke L; Richter J; Höglund M
Article: ANNALS OF INTERNAL MEDICINE. 2016;165(3):161-166

Cardiovascular Events Associated With Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Population-Based Cohort Study.

Dahlén T; Edgren G; Lambe M; Höglund M; Björkholm M; Sandin F; Själander A; Richter J; Olsson-Strömberg U; Ohm L; Bäck M; Stenke L; Swedish CML Group and the Swedish CML Register Gro
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2016;96(2):175-180

Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.

Dahlén T; Kalin M; Cederlund K; Nordlander A; Björkholm M; Ljungman P; Blennow O

Alla övriga publikationer

Letter: LEUKEMIA. 2023;37(5):1156-1159

The impact of Covid-19 in patients with chronic myeloid leukemia-a nationwide population-based study.

Dahlén T; Flygt H; Lübking A; Olsson-Strömberg U; Wennström L; Dreimane A; Själander A; Leach S; Gisslén M; Li H; Höglund M; Stenke L; Nyberg F
Thesis / dissertation: 2023

Agnostic studies in epidemiology

Dahlén, Torsten

Anställningar

Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2024-2024

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2023
Läkarexamen, Karolinska Institutet, 2012

Handledare

Enoch Chen, Extrapolating survival with applications in health technology assessment, 2021

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Handledare

Nyheter från KI

Kalenderhändelser från KI